Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Cibenzoline

Cibenzoline

pharmaceutical raw materials
Cibenzoline structure

Cibenzoline 

structure
  • CAS No:

    53267-01-9

  • Formula:

    C18H18N2

  • Chemical Name:

    Cibenzoline

  • Synonyms:

    1H-Imidazole,2-(2,2-diphenylcyclopropyl)-4,5-dihydro-;2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole;Cibenzoline;Cifenline;(RS)-Cibenzoline;(±)-Cibenzoline;UP 33-901;Ro 22-7796;125876-54-2

  • Categories:

    Active Pharmaceutical Ingredients  >  Circulatory System Drugs

Description

Cibenzoline is a diarylmethane.

Cibenzoline Basic Attributes

262.35

262.35

258-453-7

DTXSID9022819

C - Cardiovascular system

2933290090

Characteristics

24.4

2.75870

1.17 g/cm3

103.5 °C

449.2ºC

225.5ºC

1.655

LD100 in rats (mg/kg): 64 i.v. (Cognaco)

Safety Information

|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P280, P301+P312, P302+P352, P321, P330, P332+P313, P362, and P501|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)

2-(2,2-diphenylcyclopropyl)-2-imidazoline

Cibenzoline Use and Manufacturing

The first class of anti-arrhythmic drugs produces anti-arrhythmic effects by inhibiting Na+ influx of cardiomyocytes, and can extend the duration of action potentials, and can also reduce Ca2+ influx. It has the characteristics of the third and fourth types. It is used to reduce and prevent extraventricular and supraventricular contractions, prevent the onset of paroxysmal supraventricular tachycardia, and maintain sinus rhythm after recovery of atrial fibrillation and flutter.

Computed Properties

Molecular Weight:262.3
XLogP3:2.7
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:1
Rotatable Bond Count:3
Exact Mass:262.146998583
Monoisotopic Mass:262.146998583
Topological Polar Surface Area:24.4
Heavy Atom Count:20
Complexity:357
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Material

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.